Autopsy report · NCT03572062
A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults
Cause of deathOther
“Study halted prematurely by sponsor and will not resume, participants are no longer being examined or receiving intervention.”
Life of this trial
- Ran for about 2 years 2 months before it stopped.
- 317 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Respiratory Tract Infection
- Interventions
- Formulation A; Formulation B; Formulation C; Placebo
- Participants
- 317
- Sites
- 16
- Countries
- Australia, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.